CLOSTRIDIUM DIFFICILE-ASSOCIATED DIARRHOEA (CDAD) Clinical Trials

4 clinical trials for CLOSTRIDIUM DIFFICILE-ASSOCIATED DIARRHOEA (CDAD) across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• AN EXPLORATORY, OPEN LABELLED, PHASE IIA STUDY TO ASSESS SAFETY, TOLERABILITY AND EFFICACY OF INCREMENTAL DOSES OF MGB-BP-3 IN PATIENTS WITH CLOSTRIDIUM DIFFICILE-ASSOCIATED DIARRHEA (CDAD) — RECRUITING · PHASE2
• A PROSPECTIVE, MULTICENTER STUDY TO INVESTIGATE THE PHARMACOKINETICS, SAFETY, AND EFFICACY OF CADAZOLID VERSUS VANCOMYCIN IN PEDIATRIC SUBJECTS WITH CLOSTRIDIUM DIFFICILE-ASSOCIATED DIARRHEA — RECRUITING
• A PHASE 2B, PARALLEL-GROUP, DOUBLE BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF SYN-004 COMPARED TO PLACEBO FOR THE PREVENTION OF CLOSTRIDIUM DIFFICILE ASSOCIATED DIARRHEA IN PATIENTS WITH A DIAGNOSIS OF LOWER RESPIRATORY TRACT INFECTION — RECRUITING · PHASE2
• A PHASE II, RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED CLINICAL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF SMT19969 (200 MG BID) FOR 10 DAYS COMPARED WITH VANCOMYCIN (125 MG QID) FOR 10 DAYS FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE-ASSOCIATED DIARRHOEA (CDAD) — COMPLETED · PHASE2

Refine this search